4//SEC Filing
LA JOLLA PHARMACEUTICAL CO 4
Accession 0001209191-05-027489
CIK 0000920465operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 6:49 PM ET
Size
34.2 KB
Accession
0001209191-05-027489
Insider Transaction Report
Form 4
ENGBERS WILLIAM
Director
Transactions
- Award
Stock Options (right to buy)
2005-05-19+4,011→ 148,795 totalExercise: $0.34Exp: 2009-11-02→ Common Stock (4,011 underlying) - Disposition to Issuer
Stock Options (right to buy)
2005-05-19−10,846→ 137,949 totalExercise: $3.69Exp: 2007-05-19→ Common Stock (10,846 underlying) - Award
Stock Options (right to buy)
2005-05-19+10,846→ 148,795 totalExercise: $3.69Exp: 2010-01-28→ Common Stock (10,846 underlying) - Award
Stock Options (right to buy)
2005-05-19+20,000→ 148,795 totalExercise: $3.63Exp: 2008-12-03→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Options (right to buy)
2005-05-19−41,143→ 107,652 totalExercise: $0.48Exp: 2007-05-19→ Common Stock (41,143 underlying) - Award
Stock Options (right to buy)
2005-05-19+41,143→ 148,795 totalExercise: $0.48Exp: 2009-09-28→ Common Stock (41,143 underlying) - Disposition to Issuer
Stock Options (right to buy)
2005-05-19−4,011→ 144,784 totalExercise: $0.34Exp: 2007-05-19→ Common Stock (4,011 underlying) - Disposition to Issuer
Stock Options (right to buy)
2005-05-19−5,000→ 143,795 totalExercise: $2.97Exp: 2007-05-19→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Options (right to buy)
2005-05-19−20,000→ 128,795 totalExercise: $3.63Exp: 2007-05-19→ Common Stock (20,000 underlying) - Award
Stock Options (right to buy)
2005-05-19+5,000→ 148,795 totalExercise: $2.97Exp: 2013-05-12→ Common Stock (5,000 underlying)
Footnotes (6)
- [F1]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 12/03/1998. Options were fully vested on 12/03/2000.
- [F2]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 09/28/1999. Options were fully vested on 12/28/2000.
- [F3]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 11/02/1999. Options were fully vested on 12/02/2000.
- [F4]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 01/28/2000. Options were fully vested on 12/28/2000.
- [F5]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 05/12/2003. On 5/19/2005, 3,333 options were vested. Mr. Engbers ceased being a director of the Company on 05/19/2005. Immediately prior to his cessation of service as a director the vesting period was accelerated so that all options were fully vested on 5/19/2005.
- [F6]Amendment of outstanding option resulting in deemed cancellation of option and grant of replacement option. The option was originally granted on 09/18/2003. On 5/19/2005, 2,778 options were vested. Mr. Engbers ceased being a director of the Company on 05/19/2005. Immediately prior to his cessation of service as a director the vesting period was accelerated so that all options were fully vested on 5/19/2005.
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000920465
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 6:49 PM ET
- Size
- 34.2 KB